Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling
- PMID: 29709098
- DOI: 10.1111/tmi.13062
Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling
Abstract
Background: Resistance to antimonials is a fundamental determinant of treatment failure in anthroponotic cutaneous leishmaniasis (ACL). Detection of reliable molecular markers to distinguish unresponsive and responsive parasites is critical for consolidating strategies to monitor drug efficacy.
Methods: We analysed the expression of five major antimony resistance-associated genes that is aquaglyceroporin1 (AQP1), γ-glutamylcysteine synthetase (γ-GCS), multidrug resistance protein A (MRPA), trypanothione reductase (TR) and thiol-dependent reductase 1 (TDR1), in unresponsive and responsive Leishmania tropica field isolates by quantitative real-time PCR in comparison with sensitive and resistant reference strains.
Results: Gene expression analysis showed the down-regulation of AQP1, γ-GCS and TDR1 by a factor of 1.9, 1.7 and 3.55, respectively, in unresponsive isolates vs. responsive ones. The average RNA expression level of MRPA increased by a factor of 1.9 in the unresponsive group. Isolates exhibited a strong positive linear correlation between gene expression of AQP1 and γ-GCS. A negative correlation between the AQP1 and γ-GCS expression level and lesion duration in responsive patients indicated the potential role in diagnosing drug-unresponsive parasites in endemic areas of ACL.
Conclusion: In cases of inconclusive outcomes of resistance tests in clinical isolates, expression analysis of a set of influential genes can be beneficial to identify distinctive biomarkers between antimony-unresponsive and responsive parasites.
Keywords: Leishmania tropica; Iran; Leishmania tropica; antimonial resistance; genetic markers; marqueurs génétiques; qPCR en temps réel; real-time qPCR; résistance antimoniale.
© 2018 John Wiley & Sons Ltd.
Similar articles
-
Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of Iran.Acta Trop. 2022 Jun;230:106392. doi: 10.1016/j.actatropica.2022.106392. Epub 2022 Mar 8. Acta Trop. 2022. PMID: 35276060
-
Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transport.Arch Dermatol Res. 2019 Jan;311(1):9-17. doi: 10.1007/s00403-018-1872-2. Epub 2018 Nov 2. Arch Dermatol Res. 2019. PMID: 30390113
-
Expression analysis of activated protein kinase C gene (LACK1) in antimony sensitive and resistant Leishmania tropica clinical isolates using real-time RT-PCR.Int J Dermatol. 2016 Sep;55(9):1020-6. doi: 10.1111/ijd.13321. Epub 2016 Jun 23. Int J Dermatol. 2016. PMID: 27336481
-
Leishmania spp. genetic factors associated with cutaneous leishmaniasis antimony pentavalent drug resistance: a systematic review.Mem Inst Oswaldo Cruz. 2024 Sep 2;119:e230240. doi: 10.1590/0074-02760230240. eCollection 2024. Mem Inst Oswaldo Cruz. 2024. PMID: 39230137 Free PMC article.
-
Global distribution of treatment resistance gene markers for leishmaniasis.J Clin Lab Anal. 2022 Aug;36(8):e24599. doi: 10.1002/jcla.24599. Epub 2022 Jul 9. J Clin Lab Anal. 2022. PMID: 35808933 Free PMC article. Review.
Cited by
-
Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56/ARM58 transcripts and reduced drug uptake.Mem Inst Oswaldo Cruz. 2019;114:e190111. doi: 10.1590/0074-02760190111. Epub 2019 Aug 15. Mem Inst Oswaldo Cruz. 2019. PMID: 31433006 Free PMC article.
-
Nano amphotericin B: a good anti-leishmanial drug with effect on cathelicidin gene expression.J Parasit Dis. 2021 Jun;45(2):366-371. doi: 10.1007/s12639-020-01308-3. Epub 2020 Nov 13. J Parasit Dis. 2021. PMID: 34295035 Free PMC article.
-
Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice.Parasit Vectors. 2020 Aug 12;13(1):415. doi: 10.1186/s13071-020-04289-7. Parasit Vectors. 2020. PMID: 32787908 Free PMC article.
-
Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: A prospective case-control study on treatment outcome and their medical importance.PLoS Negl Trop Dis. 2021 Jan 28;15(1):e0009089. doi: 10.1371/journal.pntd.0009089. eCollection 2021 Jan. PLoS Negl Trop Dis. 2021. PMID: 33507940 Free PMC article.
-
A Systematic Review of Curcumin and its Derivatives as Valuable Sources of Antileishmanial Agents.Acta Parasitol. 2021 Sep;66(3):797-811. doi: 10.1007/s11686-021-00351-1. Epub 2021 Mar 26. Acta Parasitol. 2021. PMID: 33770343
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials